Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Biogenes Technologies logo — Diagnostics Simplified with In Silico Aptamers

Biogenes Technologies

Diagnostics Simplified with In Silico Aptamers

Founded 2015 Malaysia Malaysia 21 employees Series A Total: $11.30M Biotechnology, Health Care

General Information

Company Name Biogenes Technologies
Founded Year 2015
Location Malaysia Malaysia
Employees 21
Industries Biotechnology, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Biogenes Technologies. To contact Biogenes Technologies, visit biogenestech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biogenes Technologies compare?

A PDF of Biogenes Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biogenes Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biogenes Technologies

Biogenes Technologies is a Malaysia-based startup founded in 2015, specializing in the design, development, and commercialization of aptamer-based biosensors for molecular diagnostics applications. The company's slogan, "Diagnostics Simplified with In Silico Aptamers," encapsulates its innovative approach to simplifying diagnostics. Malaysian Technology Development Corporation made a significant investment of MYR5.50M in the company on 18 January 2023. Biogenes Technologies operates in the biotechnology and health care industries, leveraging cutting-edge technology to advance the field of molecular diagnostics.

Business keywords: molecular diagnostics, aptamers, biosensors, in silico, development, commercialization, biomedical engineering, innovation, startup, investing

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant MYR5.50M 1
Malaysian Technology Development Corporation
Malaysian Technology Development Corporation
18 Jan 2023
Series A $5.70M 1
Pembangunan Ekuiti
Pembangunan Ekuiti
18 Jan 2023
Seed Round $100.00K 1
Antler
Antler
16 Jul 2020
Pre Seed Round Undisclosed 1
Antler
Antler
01 Jan 2015

Biogenes Technologies Alternatives & Competitors

Biogenes Technologies vs
FRIZ Biochem GmbH
FRIZ Biochem GmbH Germany

Taking Point-of-Care testing to the next level.

Grant
11 employees
Biotechnology, Health Care
Biogenes Technologies vs
Geneplus-Beijing Co. Ltd.
Geneplus-Beijing Co. Ltd.

Pioneering innovative molecular biological solutions for life science and diagnostics

Series C
Biotechnology, Health Care
Biogenes Technologies vs
Revlar Diagnostics
Revlar Diagnostics United States

Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity and...

4 employees
Biotechnology, Health Care

FAQ About Biogenes Technologies

Diagnostics Simplified with In Silico Aptamers
Biogenes Technologies was founded in 2015.
Biogenes Technologies is headquartered in Malaysia.
Biogenes Technologies operates in Biotechnology and Health Care. Its work centres on molecular diagnostics, aptamers, biosensors and in silico.
Biogenes Technologies has approximately 21 employees.
Biogenes Technologies has completed 4 funding rounds, raising a total of $11.30M. The latest funding stage is Series A.
Top alternatives and competitors to Biogenes Technologies include FRIZ Biochem GmbH, Geneplus-Beijing Co. Ltd., Revlar Diagnostics, oncgnostics GmbH, AmplifiDx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biogenes Technologies and FRIZ Biochem GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biogenes Technologies, https://bouncewatch.com/company/biogenes-technologies, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes